Two Sigma Securities’s Genocea Biosciences, Inc. GNCA Stock Holding History

Two Sigma Securities’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18,578	Closed	-$50K	–	1812
2021 Q1	$50K	Buy	+18,578	New	+$55K	﹤0.01%	734
2019 Q2	–	Sell	-1,276	Closed	-$6K	–	2572
2019 Q1	$6K	Sell	1,276 -12	-0.9%	-$59	﹤0.01%	1747
2018 Q4	$3K	Buy	+1,288	New	+$6.41K	﹤0.01%	2071
2018 Q1	–	Sell	-2,430	Closed	-$23K	–	3100
2017 Q4	$23K	Buy	+2,430	New	+$24.4K	﹤0.01%	1621
2017 Q2	–	Sell	-1,302	Closed	-$63K	–	1286
2017 Q1	$63K	Buy	+1,302	New	+$50.9K	0.01%	786

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Two Sigma Securities's GNCA Position: Q2 2021 in Review

Two Sigma Securities sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2021, closing a stake of 18,578 shares — an estimated $50K sold.

Two Sigma Securities first reported a position in GNCA in Q1 2017 and held it in 5 quarters. The position peaked at $63K in Q1 2017. 46 funds tracked by Wall St. Rank hold GNCA as of Q2 2021.

Two Sigma Securities reported no remaining Genocea Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
Two Sigma Securities sold 18,578 Genocea Biosciences, Inc. shares in Q2 2021, an estimated $50K.
Two Sigma Securities first reported a position in Genocea Biosciences, Inc. in Q1 2017 and held it in 5 quarters.
Two Sigma Securities's Genocea Biosciences, Inc. position peaked at $63K in Q1 2017.
46 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2021.

Based on Two Sigma Securities's 13F filing for Q2 2021, filed 16 Aug 2021.